Smoking Cessation and Lung Cancer: Oncology Nurses Can Make a Difference
Section snippets
Smoking Prevalence Rates and the Benefits of Cessation
The prevalence of smoking among newly diagnosed lung cancer patients tends to be higher than the general population. Estimates for the prevalence of smoking have ranged from 24% to 60% among newly diagnosed lung cancer patients compared with 12% to 29% among the general US population.5, 6, 7 Although the diagnosis of lung cancer presents a compelling reason to quit smoking, studies have estimated that between 8% to 17% of smokers continue to smoke after diagnosis.5, 6 This finding underscores
The Impact of Smoking on Outcomes of Cancer Treatment Modalities
Smoking can negatively affect outcomes of cancer treatments through direct and indirect effects. Tobacco smoke and its constituents have active biological effects that can interact with cancer treatments. Moreover, the type and severity of smoking-related comorbidities may affect the type of cancer treatments chosen. For example, severe lung or cardiovascular disease may limit the option for or extent of lung cancer surgery, use of radiation treatment, or type of chemotherapy agent that can be
Understanding Tobacco Dependence
In 1988, the Surgeon General's Report on Nicotine Addiction18 provided conclusive evidence that tobacco is addicting in the same way as other drugs that are responsible for addiction. In fact, nicotine, the dependence-producing substance in tobacco, is similar to heroin and cocaine in its addictive properties. This landmark report promoted the fact that tobacco dependence is a chronic condition characterized by periods of abstinence and relapse, thus requiring repeated interventions by
Conclusion
Smoking cessation after the diagnosis of lung cancer is essential to improve clinical outcomes. Although effective TDT are available to help smokers quit smoking, persistent efforts over repeated contacts may be necessary to achieve long-term cessation. Oncology nurses have the potential to make an enormous difference in the successful integration of tobacco-dependence services into clinical settings. Further knowledge and training in TDT is needed to make this a reality.
Mary E. Cooley PhD, APRN, BC: Nurse Scientist, Phyllis F. Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA.
References (35)
- et al.
The relationship between cigarette smoking and quality of life after lung cancer diagnosis
Chest
(2004) - et al.
Effect of preoperative smoking intervention on postoperative complications: a randomized clinical trial
Lancet
(2002) - et al.
Smoking and timing of cessation: impact on pulmonary complications after thoracotomy
Chest
(2005) - et al.
Evaluation of infections in non-small cell lung cancer is associated with decreased chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival
Cancer Detect Prev
(2005) - et al.
Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells
Int J Oral Maxillofac Surg
(2007) - et al.
Nicotine withdrawal and nicotine replacement in the palliative care setting
J Pain Symptom Manage
(2005) - et al.
Treating tobacco dependence: review of the best and latest treatment options
J Thorac Oncol
(2007) - et al.
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention
Mayo Clin Proc
(2007) - et al.
Tobacco dependence curricula in U.S. baccalaureate and graduate nursing education
Nurs Outlook
(2004) Cancer Facts and Figures–2007
(2007)
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
Ann Intern Med
Smoking abstinence and small cell lung cancer survival: an association
JAMA
Nicotine dependence treatment for patients with cancer
Cancer
Tobacco use in women with lung cancer
Ann Behav Med
Centers for Disease Control and Prevention: State-specific prevalence of current cigarette smoking among adults and secondhand smoke rules and policies in homes and workplaces
MMWR Morbid Mortal Wkly Rep
US Department of Health and Human Services: Clinical practice guideline: treating tobacco use and dependence. A report from the surgeon general
Does smoking cessation improve health-related quality of life
Ann Behav Med
Cited by (39)
The Role and Scope of Prehabilitation in Cancer Care
2020, Seminars in Oncology NursingCitation Excerpt :Lung cancer is often related to smoking.2 Smoking cessation has both short- and long-term benefits, and oncology nurses can assist patients with cessation.22 Often, patients with lung cancer have chronic obstructive pulmonary disease, increasing both the risk and subsequently the rewards of exercise.
Le sevrage tabagique dans le cancer bronchique: les méthodes et les résultats; place de la e-cigarette
2019, Revue des Maladies Respiratoires ActualitesSmoking cessation: Avoiding cancer, reducing treatments toxicities and risk of relapse
2018, Revue des Maladies Respiratoires ActualitesImplementation of Tobacco Dependence Treatment Programs in Oncology Settings
2016, Seminars in Oncology NursingCitation Excerpt :Implementation, however, requires planning and collaboration among many facets of the health care system.22 Nurses educated about tobacco control and smoking cessation are critical to these efforts and have proven to effectively deliver such interventions.15,26,27 Although grass roots advocacy can be effective, buy-in and commitment from health care systems' leadership and other stakeholders are important for sustainability.
A pilot randomized controlled trial of smoking cessation in an outpatient respirology clinic
2015, Canadian Respiratory JournalSupportive care in lung cancer: Milestones over the past 40 years
2015, Journal of Thoracic OncologyCitation Excerpt :Not only is a risk factor for health and well-being but also it interferes with interventions with patients. Policy changes are needed to ensure that treatment of tobacco dependence occurs during the entire continuum of LC care.94 Addressing tobacco use as part of supportive care is an important part of reducing cancer-related morbidity and mortality.95
Mary E. Cooley PhD, APRN, BC: Nurse Scientist, Phyllis F. Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA.
Rebecca L. Sipples, APRN: Thoracic Oncology Nurse Practitioner, Yale Comprehensive Cancer Center, Yale University School of Nursing, New Haven, CT.
Meagan Murphy, BS: Research Intern, Phyllis F. Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA.
Linda Sarna RN, DNSc, FAAN: Professor, University of California-Los Angeles, School of Nursing, Los Angeles, CA.
Supported in part by grants from the National Cancer Institute (grant no. 1K07 CA92692, Mary E. Cooley, PI).